Resident mucosal programmes in colon cancer: organ-associated formation and remodelling of the immune niche
- 1Department of Digestive Diseases, The First People's Hospital of Wenling (Taizhou University Affiliated Wenling Hospital), School of Medicine, Taizhou University
- 2Tongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University
Abstract
Resident epithelial, immune and stromal cells organise immune responses in the colonic mucosa, but their contribution to the immune environment of colon cancer remains incompletely understood. We propose that colonic tumours may partly use pre-existing mucosal cells and regulatory mechanisms, a possibility we refer to as co-option. Chronic colitis provides a comparison for examining changes in mucosal immunity, without implying that inflammation is a necessary precursor to sporadic colon cancer. Colonic BTNL3/BTNL8 proteins regulate resident γδ T-cell subsets, and compartmentalised antigen presentation shapes local immune responses. In mouse models of colitis-associated cancer, resident stromal cells give rise to MCAM ⁺ cancer-associated fibroblasts that promote macrophage recruitment through IL-34/CCL8 signalling. Tumour-associated immune changes include shifts in γδ T-cell subset composition and altered functions of RORγt ⁺ regulatory T cells. MHC class II-dependent interactions between group 3 innate lymphoid cells and T cells also support microbiota-dependent antitumour immunity. Shared signalling is exemplified by the IL-22–oncostatin M–STAT3 pathway in experimental colitis and colitis-associated cancer. However, similarity in cell states and signalling does not establish that tumours preserve pre-existing multicellular mucosal niches. Much of the causal evidence derives from colitis-associated cancer models, and its relevance to sporadic colon cancer remains uncertain. Whether tumours use the same mucosal cells and regulatory mechanisms requires direct testing. Defining tumour-associated changes in these mechanisms may reveal therapeutic targets while preserving protective intestinal immunity.
Related
- Fibronectin matrix remodelling modulates the active nematic dynamics of cancer-associated fibroblasts
- Commentary: acupuncture-associated gastric mucosal repair and the EGF–EGFR-related signaling network: evidence, limitations, and prospects
- C3a receptor signalling in ObRb-expressing neurons promotes leptin resistance and obesity-associated cardiac remodelling
- Gonadal remodelling in socially driven sex change is associated with novel and known sex genes, epigenetic reprogramming, and inflammation-mediated apoptosis.
- A mucosal barrier injury related six gene transcriptomic signature associated with ulcerative colitis using machine learning and public transcriptomic data
BibTeX
@article{jiang2026resident,
title = {{Resident mucosal programmes in colon cancer: organ-associated formation and remodelling of the immune niche}},
author = {Wenjun Jiang and Bochen Pan and Zijuan Song and Zhongcheng Zhang and Haifan Yan},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1980704},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1980704/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Resident mucosal programmes in colon cancer: organ-associated formation and remodelling of the immune niche
AU - Wenjun Jiang
AU - Bochen Pan
AU - Zijuan Song
AU - Zhongcheng Zhang
AU - Haifan Yan
PY - 2026
DA - 2026/10/29
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1980704
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1980704/full
AB - Resident epithelial, immune and stromal cells organise immune responses in the colonic mucosa, but their contribution to the immune environment of colon cancer remains incompletely understood. We propose that colonic tumours may partly use pre-existing mucosal cells and regulatory mechanisms, a possibility we refer to as co-option. Chronic colitis provides a comparison for examining changes in mucosal immunity, without implying that inflammation is a necessary precursor to sporadic colon cancer. Colonic BTNL3/BTNL8 proteins regulate resident γδ T-cell subsets, and compartmentalised antigen presentation shapes local immune responses. In mouse models of colitis-associated cancer, resident stromal cells give rise to MCAM ⁺ cancer-associated fibroblasts that promote macrophage recruitment through IL-34/CCL8 signalling. Tumour-associated immune changes include shifts in γδ T-cell subset composition and altered functions of RORγt ⁺ regulatory T cells. MHC class II-dependent interactions between group 3 innate lymphoid cells and T cells also support microbiota-dependent antitumour immunity. Shared signalling is exemplified by the IL-22–oncostatin M–STAT3 pathway in experimental colitis and colitis-associated cancer. However, similarity in cell states and signalling does not establish that tumours preserve pre-existing multicellular mucosal niches. Much of the causal evidence derives from colitis-associated cancer models, and its relevance to sporadic colon cancer remains uncertain. Whether tumours use the same mucosal cells and regulatory mechanisms requires direct testing. Defining tumour-associated changes in these mechanisms may reveal therapeutic targets while preserving protective intestinal immunity.
SN - 1664-3224
ER -